Editorial Board

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

Our editorial board is comprised of clinical and pharmacological experts, organized primarily by disease focus. Most disease types now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].

Editor-in-Chief

PeterYang.jpg
Peter C. Yang, MD
Boston, MA

Social-twitter-icon.png Hem_Onc
Dr. Yang is board certified in Hematology and Medical Oncology; he practices at an academically affiliated institution in Massachusetts.

Deputy Editor

Warner Jeremy2 compact.jpg
Jeremy L. Warner, MD, MS, FAMIA, FASCO
Vanderbilt University
Nashville, TN

Social-twitter-icon.png Hemoncwarner
LinkedIn
Dr. Warner is board certified in Hematology, Medical Oncology, and Clinical Informatics; he practices at the Vanderbilt-Ingram Cancer Center. He is an Associate Professor of Medicine (Hematology/Oncology) and Biomedical Informatics at Vanderbilt University.

Associate Editors

Evidence-based Oncology
Bishalgyawali.jpg
Bishal Gyawali, MD, PhD
Queen’s University
Kingston, Canada

Social-twitter-icon.png oncology_bg
Dr. Gyawali is an Associate Professor in the Departments of Oncology and Public Health Sciences at Queen’s University, Kingston, Canada and an Ontario Institute for Clinical Research-Scientist II. He is an advocate of a "cancer groundshot", a term he coined to imply that investment should be made on proven high-value interventions in cancer care that are easy to implement globally and are affordable.

Section Editors

Breast Oncology
Fernandes Hermina WEB160x200.jpg
H. Deepika Fernandes, MD, FACP
Bismarck, ND
Dr. Fernandes is board certified in Medical Oncology and Hematology; she practices at the Edith Sanford Breast Center at Sanford Health. She is a clinical associate professor at the University of North Dakota.
Dermatologic Oncology
Bethbuchbinder.jpg
Elizabeth Buchbinder, MD
Boston, MA

LinkedIn
Dr. Buchbinder is board certified in Medical Oncology; she practices at the Dana-Farber Cancer Institute. She is an instructor at Harvard Medical School.
Endocrine Oncology
Unfilled If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Gastrointestinal Oncology
Nkv.jpg
Neeta K. Venepalli, MD, MBA
Chicago, IL
Dr. Venepalli is board certified in Medical Oncology; she practices and is an Associate Professor of Medicine (Oncology) at the University of North Carolina at Chapel Hill.
Genitourinary Oncology
Alikhaki.jpg
Ali Raza Khaki, MD
Palo Alto, CA
Dr. Khaki is board certified in Hematology and Medical Oncology; he practices at Stanford Health Care. He is a a Clinical Assistant Professor of Oncology at Stanford University School of Medicine.
Gynecologic Oncology
Brown-alaina.jpeg
Alaina J. Brown, MD, MPH
Nashville, TN
Dr. Brown is board certified in Gynecologic Oncology and Obstetrics and Gynecology; she practices at the Vanderbilt-Ingram Cancer Center. She is an Assistant Professor of Obstetrics and Gynecology at Vanderbilt University.
Head & Neck Cancer
Michaelgibson.jpg
Michael K. Gibson, MD, PhD, FACP
Nashville, TN

Social-twitter-icon.png mgibson21212
LinkedIn
Dr. Gibson is board certified in Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an associate professor at Vanderbilt University.
Neuro-Oncology
SeemaNagpal.jpg
Seema Nagpal, MD
Palo Alto, CA
Dr. Nagpal is board certified in Neurology and UCNS certified in Neuro-Oncology; she practices at Stanford Health Care. She is a clinical associate professor at Stanford University
Sarcoma
Elizabethdavis2.jpg
Elizabeth J. Davis, MD
Nashville, TN

Social-twitter-icon.png ejdavis25
Dr. Davis is board certified in Medical Oncology; she practices at the Vanderbilt-Ingram Cancer Center. She is an assistant professor at Vanderbilt University.
Thoracic Oncology
Amit Kulkarni.jpg
Amit Kulkarni, MBBS
University of Minnesota
Minneapolis, MN

Social-twitter-icon.png AmitKulkarniMD
Dr. Kulkarni is board certified in Internal Medicine and board eligible in Medical Oncology; he practices and is an Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation at the University of Minnesota.
Acute Leukemias
MartinSchoen.jpg
Martin W. Schoen, MD, MPH
Saint Louis University
St. Louis, MO
Dr. Schoen is board certified in Internal Medicine and board eligible in Hematology and Medical Oncology; he practices at the Saint Louis Veterans Affairs Medical Center. He is an assistant professor at Saint Louis University.
Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Sanjay mohan.png
Sanjay R. Mohan, MD, MSCI
Nashville, TN
Dr. Mohan is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Aggressive Lymphomas & Lymphoproliferative disorders
TarsheenSethi.jpg
Tarsheen K. Sethi, MD, MSCI
Yale University
New Haven, CT

Social-twitter-icon.png tarsheen2
Dr. Sethi is board certified in Hematology and Medical Oncology; she practices at the Smilow Cancer Hospital at Yale New Haven. She is an assistant professor at Yale University.
Indolent Lymphomas
Sanjaisharma.jpg
Sanjai Sharma, MD
Visalia, CA
Dr. Sharma is board certified in Hematology and Medical Oncology; he practices at the Sequoia Regional Cancer Center.
Plasma Cell Dyscrasias
Headshot Cowan.jpg
Andrew J. Cowan, MD
Seattle, WA

Social-twitter-icon.png andrewcowanmd
LinkedIn
Dr. Cowan is board certified in Hematology and Medical Oncology; he practices at the Seattle Cancer Care Alliance. He is an assistant professor at the University of Washington.
T-cell and NK-cell neoplasms
Bdholaria.jpg
Bhagirathbhai Dholaria, MBBS
Nashville, TN
Dr. Dholaria is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.
Histiocyte Disorders
GauravGoyal.jpg
Gaurav Goyal, MD
UAB
Birmingham, AL

Social-twitter-icon.png GauravGoyalMD
Dr. Goyal is board certified in Hematology and Medical Oncology; he practices at UAB Medicine. He is an assistant professor at UAB (The University of Alabama at Birmingham).
Pediatric Leukemia & Lymphoma
Liang.jpg
Wayne H. Liang, MD, MS, FAMIA
Atlanta, GA

Social-twitter-icon.png WayneLiangMD
LinkedIn
Dr. Liang is board certified in Pediatrics, Pediatric Hematology-Oncology, and Clinical Informatics; he practices at Children’s Healthcare of Atlanta. He is an Assistant Professor of Pediatrics at Emory University.
Pediatric Neuro-Oncology & Solid Tumors
Nwood.jpeg
Nikki M. Wood, DO
Kansas City, MO

Social-twitter-icon.png WoodNikkiM
LinkedIn
Dr. Wood is board certified in Pediatrics and Pediatric Hematology-Oncology; she practices at Children's Mercy Kansas City. She is an Assistant Professor of Pediatrics at the University of Missouri-Kansas City School of Medicine.
Pediatric Sarcoma
Dargan Chandni.jpg
Chandni Dargan, MD
Kansas City, MO

LinkedIn
Dr. Dargan is board certified in Pediatrics; she practices at Children's Mercy Kansas City. She is a Clinical Assistant Professor of Pediatrics and Pediatric Clinical Pharmacology Fellow at the University of Missouri-Kansas City School of Medicine.
Immuno-Oncology
Mooradian.jpg
Meghan J. Mooradian, MD
Boston, MA

LinkedIn
Dr. Mooradian is board certified in Medical Oncology; she practices at Massachusetts General Hospital. She is an instructor at Harvard Medical School.
Transplant
Hilal.jpg
Talal Hilal, MD
University of Mississippi
Jackson, MS

Social-twitter-icon.png THilalMD
Dr. Hilal is board certified in Hematology and Medical Oncology; he practices at University of Mississippi Medical Center. He is an assistant professor at the University of Mississippi.
Classical Hematology
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Nashville, TN
Dr. Tillman is board certified in Hematology and Medical Oncology; he practices at the Vanderbilt-Ingram Cancer Center. He is an assistant professor at Vanderbilt University.

Page Editors

COI Disclosures

Please see our conflict of interest page for more details.

Name Research funding Other (honoraria, travel support, significant ownership interests, etc.) Date of disclosure
Jon Arnason Nothing to disclose Nothing to disclose November 10, 2021
Alaina J. Brown NIH Nothing to disclose October 13, 2021
Elizabeth Buchbinder NIH; Trial funding to institution: Eli Lilly, Novartis, Partners therapeutics, Genentech, BVD Consulting/Advisory Board: Novartis, Apexigen, Shionogi, BMS April 15, 2021
Karine A. Darbinyan Nothing to disclose Nothing to disclose November 11, 2021
Chandni Dargan Nothing to disclose Consulting: Westat November 16, 2021
Elizabeth J. Davis Research funding: NIH/NCI; ECOG
Trial funding to institution: Karyopharm, BMS, Incyte, Actuate, Bio Atla, Top Alliance Biosciences, Genentech
Consulting/Advisory Board: Deciphera November 10, 2021
Bhagirathbhai Dholaria Institutional research funding (no personal payment): Takeda, Janssen, Angiocrine, Pfizer, Poseida, MEI, Orca, Sorrento, NHLBI Consulting/Advisory Board: Jazz, Gamida Cell; Editorship: Wiley April 2, 2021
H. Deepika Fernandes Nothing to disclose Nothing to disclose April 3, 2021
Michael K. Gibson Nothing to disclose Nothing to disclose November 15, 2021
Gaurav Goyal Nothing to disclose Nothing to disclose April 1, 2021
Laura Graham Nothing to disclose Nothing to disclose October 11, 2020
Bishal Gyawali Nothing to disclose Consulting/Advisory Board: Vivio Health October 12, 2021
Talal Hilal Nothing to disclose Consulting/Advisory Board: Incyte
Editorship: Springer
November 16, 2021
Ali R. Khaki Nothing to disclose Consulting/Advisory Board: Seagen/Astellas
Travel: BCAN; SABCS
Honoraria: Onclive CME
November 11, 2021
Ashwin Kishtagari Nothing to disclose Nothing to disclose November 1, 2021
Mary L. Kwok Nothing to disclose Nothing to disclose April 1, 2021
Wayne H. Liang Nothing to disclose Consulting/Advisory Board: Westat November 10, 2021
Eric Marks Nothing to disclose Nothing to disclose October 12, 2020
Ronak H. Mistry Nothing to disclose Nothing to disclose October 15, 2021
Sanjay R. Mohan Novartis, Celgene Nothing to disclose December 31, 2020
Meghan J. Mooradian Nothing to disclose Consulting/Advisory Board: AstraZeneca, Nektar Pharmaceuticals, Immunai October 15, 2020
Seema Nagpal Trial funding to institution: Agios, PharmAbcine, Insightec, Berg, Inovio Consulting/Advisory Board: SeaGen, Novocure Steering Committee, Biocept Steering Committee; Guidelines: NCCN CNS committee, ARS-AUC CNS committee, ASTRO Brain metastases guideline committee April 12, 2021
Ryan Nguyen Nothing to disclose Honoraria: Promega November 18, 2021
Samuel R. Rubinstein Nothing to disclose Consulting/Advisory Board: Sanofi, Roche, Janssen, EUSA pharma October 11, 2021
Martin Schoen Nothing to disclose Nothing to disclose April 2, 2021
Sanjai Sharma Nothing to disclose Nothing to disclose April 12, 2021
Eric K. Singhi Nothing to disclose Nothing to disclose October 26, 2021
Benjamin F. Tillman Nothing to disclose Nothing to disclose October 13, 2021
Jeremy L. Warner AACR; NIH; Vanderbilt University Travel: AACR; ASCO
Ownership: HemOnc.org
Consulting/Advisory Board: Westat, Roche, Flatiron Health
October 13, 2021
Risa L. Wong Nothing to disclose Nothing to disclose November 12, 2021
Nikki M. Wood Nothing to disclose Consulting/Advisory Board: Westat November 10, 2021
Peter C. Yang Nothing to disclose Ownership: HemOnc.org
Stock: Merck, Pfizer
October 12, 2020